Unknown

Dataset Information

Clinical outcomes of second-generation limus-eluting stents compared to paclitaxel-eluting stents for acute myocardial infarction with cardiogenic shock.


ABSTRACT:

Objective

Whether the cardiovascular (CV) outcomes of second-generation limus-eluting stents (LESs) differ from those of paclitaxel-eluting stents (PESs) in patients with acute myocardial infarction (AMI) complicated by cardiogenic shock (CS) is still unclear.

Methods

We used the Taiwan National Health Insurance Research Database to analyse data of 516 patients with AMI and CS diagnosed from January 2007 to December 2011. We used propensity score matching to adjust for the imbalance in covariate baseline values between these two groups. We evaluated clinical outcomes by comparing 197 subjects who used second-generation LESs to 319 matched subjects who used PESs.

Results

The risk of the primary composite outcomes (i.e., myocardial infarction, coronary revascularisation

SUBMITTER: Mao CT 

PROVIDER: S-EPMC6447233 | biostudies-literature | 2019

REPOSITORIES: biostudies-literature